Dr. Reddy’s Laboratories is a leading pharmaceutical company in India with a share price of 52 week high/low and daily volume. The company has a market cap of Rs 2,200 crore and a dividend yield of 1.5%. Dr. Reddy’s Laboratories is also the second largest generic pharmaceutical company in the world by revenue.
What is the current share price of Dr. Reddy’s Laboratories
Dr. Reddy’s Laboratories is an Indian multinational pharmaceutical company based in Hyderabad, Telangana, that was founded in 1984. The company went public in 1993 and is now listed on the Bombay Stock Exchange and National Stock Exchange of India. As of 2019, it has a market capitalization of ₹176 billion (US$2.4 billion).
The company manufactures and sells pharmaceutical formulations and active pharmaceutical ingredients (APIs) primarily in India and the United States. It has over 190 medications, 60 APIs, and 30 animal health products in various therapeutic categories. The company’s major therapeutic areas of focus are gastrointestinal, cardiovascular, diabetology, oncology, pain management, and anti-infective. In addition to manufacturing its own products, Dr. Reddy’s also contract manufactures for other companies.
What was the share price of Dr. Reddy’s Laboratories one year ago
The share price of Dr. Reddy’s Laboratories one year ago was $30.36. Dr. Reddy’s Laboratories is a pharmaceutical company that is based in India. The company manufactures and sells a wide range of generic drugs. The company has a strong presence in the Indian market and is expanding its operations in other countries as well. Dr. Reddy’s Laboratories is a well-established company with a good reputation. The company’s products are of high quality and are affordable. The company is expected to continue to grow at a rapid pace in the future.
What is the 52 week high and low for Dr. Reddy’s Laboratories shares
Dr. Reddy’s Laboratories is an Indian pharmaceutical company with a market capitalization of over $12 billion. The company’s 52 week high and low stock price is $3.92 and $2.63, respectively. The company’s shares are traded on the Bombay Stock Exchange and the National Stock Exchange of India.
How many shares of Dr. Reddy’s Laboratories are traded daily on the stock market
According to Yahoo Finance, an average of 5.4 million shares of Dr. Reddy’s Laboratories are traded on the stock market every day.
What is the market capitalization of Dr. Reddy’s Laboratories
Dr. Reddy’s Laboratories is a pharmaceutical company with a market capitalization of $15.4 billion as of March 2020. The company was founded in 1984 by Anji Reddy, who had previously worked in the Indian pharmaceutical industry. Dr. Reddy’s Laboratories is headquartered in Hyderabad, India and has over 50,000 employees. The company’s products include generic drugs, over-the-counter drugs, and branded drugs. Dr. Reddy’s Laboratories is the second-largest pharmaceutical company in India and the fifth-largest generic drug company in the world.
Who are the major shareholders of Dr. Reddy’s Laboratories
Dr. Reddy’s Laboratories is a publicly traded company with shares listed on the Bombay and National Stock Exchanges. As of March 31, 2020, the top 10 shareholders of Dr. Reddy’s Laboratories (in terms of percentage of total shareholding) are as follows:
1. Fidelity Investments Mauritius LLC – 10.18%
2. T Rowe Price International Ltd. – 7.67%
3. SBI Magnum Global Fund – 5.73%
4. Norges Bank Investment Management – 3.96%
5. OppenheimerFunds Inc. – 3.93%
6. BlackRock Inc. – 2.71%
7. JPMorgan Asset Management (UK) Ltd. – 2.62%
8. The Vanguard Group Inc. – 2.47%
9. Dimensional Fund Advisors LP – 1.80%
10. FIL Limited – 1.74%
These 10 shareholders collectively own approximately 50% of Dr. Reddy’s Laboratories shares outstanding.
What analyst rating does Dr. Reddy’s Laboratories currently have
Dr. Reddy’s Laboratories is a leading pharmaceutical company with a strong presence in India and other emerging markets. The company has a current analyst rating of “overweight” from most major research firms. This rating is based on the company’s strong financials, experienced management team, and growing market share. Dr. Reddy’s Laboratories is well-positioned to continue its growth trajectory in the coming years.
What is the price to earnings ratio for Dr. Reddy’s Laboratories shares
As of July 2020, the price-to-earnings (P/E) ratio for Dr. Reddy’s Laboratories shares was 20.92.
This means that for every rupee of earnings, the company’s stock was trading at 20.92 rupees.
Dr. Reddy’s Laboratories is a pharmaceutical company based in India. The company’s shares are listed on the Bombay Stock Exchange and the National Stock Exchange of India.
The P/E ratio is a measure of how much investors are willing to pay for each rupee of a company’s earnings. A high P/E ratio indicates that investors are willing to pay more for the company’s shares, relative to its earnings.
Dr. Reddy’s Laboratories has a long history of dividend payments, and its shares have consistently outperformed the Indian stock market over the long term. The company’s shares are therefore considered to be a good investment for long-term growth.
What is the dividend yield for Dr. Reddy’s Laboratories shares
If you’re looking for the dividend yield for Dr. Reddy’s Laboratories shares, you’re in the right place! Here at Dividend Yield, we like to keep things simple and easy to understand. So without further ado, let’s take a look at the dividend yield for Dr. Reddy’s Laboratories shares.
Dr. Reddy’s Laboratories is a pharmaceutical company based in India. The company was founded in 1984 and it is currently one of the largest pharmaceutical companies in India. The company offers a wide range of products and services, including prescription drugs, over-the-counter drugs, and generic drugs.
The dividend yield for Dr. Reddy’s Laboratories shares is 2.5%. This means that for every share that you own, you will receive 2.5% of the company’s profits as a dividend payment.
So there you have it! That’s the dividend yield for Dr. Reddy’s Laboratories shares. We hope this article has been helpful in explaining what the dividend yield is and how it works. Thanks for reading and we wish you the best of luck in your investing journey!
When is the next earnings release date for Dr. Reddy’s Laboratories
The next earnings release date for Dr. Reddy’s Laboratories is on May 14, 2020.